Adding calcium to EDTA plasma samples prior to analysis could solve the compatibility issue in commercially available ELISAs that are standardized for serum.
Tenland E, Hillman M
Purpose
Conclusion
Studies (1)
Purpose
The purpose of this study was to determine the effects of analyzing EDTA plasma rather than serum and adding CaCl2 to EDTA plasma on results of the quantikine human sCD163 ELISA. The manufacturer recommends against the use of EDTA plasma in this ELISA but claims that it is suitable for use with serum and heparin plasma. Specimens were obtained from 49 diabetic patients and serum and plasma were stored at -20 degrees C until analysis. An aliquot of EDTA plasma was thawed and incubated with CaCl2 overnight at 4 degrees C.
Summary of Findings
While the majority of EDTA plasma specimens assayed by the sCD163 ELISA performed similarly to serum, some EDTA plasma specimens gave significantly higher sCD163 measurements than their serum counterparts. Overnight incubation of EDTA plasma with CaCl2 was able to attenuate the falsely high results so that there was no effective bias between the plasma and corresponding serum specimens.
Biospecimens
FluidPlasmaFluidSerumFluidBloodPreservation Types
FrozenDiagnoses
Diabetes Type 1Diabetes Type 2Platforms
ProteinELISAPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Biospecimen Acquisition Anticoagulant EDTANoneBiospecimen Aliquots and Components Biospecimen components 25 mM CaCl2No added CaCl2Biospecimen Aliquots and Components Blood and blood products PlasmaSerum